Thoracic injection of low-dose interleukin-2 as an adjuvant therapy improves the control of the malignant pleural effusions: a systematic review and meta-analysis base on Chinese patients

Thoracic injection of low-dose interleukin-2 as an adjuvant therapy improves the control of the malignant pleural effusions: a systematic review and meta-analysis base on Chinese patients

Abstract Background Interleukin-2 (IL-2) is an important immunotherapy cytokine for various diseases including cancer. Some studies reported the efficacy and safety on cisplatin combined with IL-2 versus cisplatin alone for treating malignant pleural effusion (MPE) through thoracic injection. Method...

Full description

Bibliographic Details
Main Authors: Liping Han, Qiufang Jiang, Wei Yao, Tian Fu, Qingdi Zeng
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Cancer
Subjects:
Malignant pleural effusions
Interleukin-2
IL-2
Cisplatin
Thoracic injection
Meta-analysis
Online Access:http://link.springer.com/article/10.1186/s12885-018-4581-5

Internet

http://link.springer.com/article/10.1186/s12885-018-4581-5

Similar Items